ETF constituents for IBRN

Below, a list of constituents for IBRN (iShares Neuroscience and Healthcare ETF) is shown. In total, IBRN consists of 80 securities.

Note: The data shown here is as of date Feb 28, 2025 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
CPRX CATALYST PHARMACEUTICALS INC Health Care Equity 171195.54 5.23
ARGX ARGENX SE ADR Health Care Equity 151157.58 4.62
ITCI INTRA CELLULAR THERAPIES INC Health Care Equity 147430.66 4.51
NBIX NEUROCRINE BIOSCIENCES INC Health Care Equity 147301.6 4.5
ALKS ALKERMES Health Care Equity 146141.4 4.47
ACAD ACADIA PHARMACEUTICALS INC Health Care Equity 145441.62 4.45
326030 SK BIOPHARMACEUTICALS LTD Health Care Equity 141394.33 4.32
PTCT PTC THERAPEUTICS INC Health Care Equity 141385.51 4.32
SRRK SCHOLAR ROCK HOLDING CORP Health Care Equity 138945.8 4.25
SUPN SUPERNUS PHARMACEUTICALS INC Health Care Equity 136793.76 4.18
BIIB BIOGEN INC Health Care Equity 133946.4 4.1
XENE XENON PHARMACEUTICALS INC Health Care Equity 132415.14 4.05
DNLI DENALI THERAPEUTICS INC Health Care Equity 126504.18 3.87
BHVN BIOHAVEN LTD Health Care Equity 121857.28 3.73
IART INTEGRA LIFESCIENCES HOLDINGS CORP Health Care Equity 112559.04 3.44
HLUN B H. LUNDBECK CLASS B Health Care Equity 97844.03 2.99
SRPT SAREPTA THERAPEUTICS INC Health Care Equity 93205.24 2.85
EWTX EDGEWISE THERAPEUTICS INC Health Care Equity 81511.04 2.49
DYN DYNE THERAPEUTICS INC Health Care Equity 65019.51 1.99
NEU NEUREN PHARMACEUTICALS LTD Health Care Equity 59774.61 1.83
AXGN AXOGEN INC Health Care Equity 57810.92 1.77
BIOA B BIOARCTIC CLASS B Health Care Equity 55360.29 1.69
AVXL ANAVEX LIFE SCIENCES CORP Health Care Equity 55134.96 1.69
PRAX PRAXIS PRECISION MEDICINES INC Health Care Equity 54291.93 1.66
AVDL AVADEL PHARMACEUTICALS ORD Health Care Equity 51444.16 1.57
DYVOX DYNAVOX GROUP Information Technology Equity 47650.69 1.46
4592 SANBIO LTD Health Care Equity 44826.85 1.37
PRTA PROTHENA PLC Health Care Equity 40219.82 1.23
ZVRA ZEVRA THERAPEUTICS INC Health Care Equity 31566.86 0.97
CAPR CAPRICOR THERAPEUTICS INC Health Care Equity 30379.06 0.93
CBLL CERIBELL INC Health Care Equity 30322.24 0.93
DNTH DIANTHUS THERAPEUTICS INC Health Care Equity 27486.54 0.84
MEDCL MEDINCELL SA Health Care Equity 25929.66 0.79
RGNX REGENXBIO INC Health Care Equity 24562.2 0.75
CLPT CLEARPOINT NEURO INC Health Care Equity 24465.21 0.75
NPCE NEUROPACE INC Health Care Equity 23965.8 0.73
2172 MICROPORT NEUROTECH CORP Health Care Equity 23932.0 0.73
DRUG BRIGHT MINDS BIOSCIENCES INC Health Care Equity 19420.5 0.59
VNDA VANDA PHARMACEUTICALS INC Health Care Equity 19194.56 0.59
AMLX AMYLYX PHARMACEUTICALS INC Health Care Equity 19138.14 0.59
SLDB SOLID BIOSCIENCES INC Health Care Equity 17313.48 0.53
TSHA TAYSHA GENE THERAPIES INC Health Care Equity 16408.92 0.5
NVRO NEVRO CORP Health Care Equity 15452.64 0.47
TRDA ENTRADA THERAPEUTICS INC Health Care Equity 15329.6 0.47
SANN SANTHERA N AG Health Care Equity 15105.57 0.46
IDIA IDORSIA N LTD Health Care Equity 14994.74 0.46
ANNX ANNEXON INC Health Care Equity 14868.56 0.45
NGNE NEUROGENE INC Health Care Equity 14340.66 0.44
ABEO ABEONA THERAPEUTICS INC Health Care Equity 14334.84 0.44
RAPP RAPPORT THERAPEUTICS INC Health Care Equity 13924.08 0.43
VYGR VOYAGER THERAPEUTICS INC Health Care Equity 12269.18 0.38
FULC FULCRUM THERAPEUTICS INC Health Care Equity 11056.81 0.34
SGMO SANGAMO THERAPEUTICS INC Health Care Equity 9634.7 0.29
DSGN DESIGN THERAPEUTICS INC Health Care Equity 8637.41 0.26
CTNM CONTINEUM THERAPEUTICS INC CLASS A Health Care Equity 6773.22 0.21
ALEC ALECTOR INC Health Care Equity 6520.68 0.2
LRMR LARIMAR THERAPEUTICS INC Health Care Equity 5937.8 0.18
CLYM CLIMB BIO INC Health Care Equity 5630.13 0.17
SAVA CASSAVA SCIENCES INC Health Care Equity 4318.73 0.13
ANRO ALTO NEUROSCIENCE INC Health Care Equity 4038.5 0.12
MARGIN_USD FUTURES USD MARGIN BALANCE Cash and/or Derivatives Cash Collateral and Margins 0.63 0.0
CHF CHF/USD Cash and/or Derivatives FX 0.34 0.0
SEK SEK/USD Cash and/or Derivatives FX -0.05 0.0
DKK DKK/USD Cash and/or Derivatives FX -0.02 0.0
JPY JPY/USD Cash and/or Derivatives FX -0.02 0.0
AUD AUD/USD Cash and/or Derivatives FX -0.01 0.0
CHF CHF/USD Cash and/or Derivatives FX -0.01 0.0
EUR EUR/USD Cash and/or Derivatives FX -0.01 0.0
HKD HKD/USD Cash and/or Derivatives FX -0.01 0.0
KRW KRW/USD Cash and/or Derivatives FX -1.75 0.0
EUR EUR CASH Cash and/or Derivatives Cash -606.48 -0.02
HKD HKD CASH Cash and/or Derivatives Cash -883.36 -0.03
CHF CHF CASH Cash and/or Derivatives Cash -1305.0 -0.04
DKK DKK CASH Cash and/or Derivatives Cash -1679.27 -0.05
JPY JPY CASH Cash and/or Derivatives Cash -2161.06 -0.07
AUD AUD CASH Cash and/or Derivatives Cash -2610.28 -0.08
SEK SEK CASH Cash and/or Derivatives Cash -5239.53 -0.16
KRW KRW CASH Cash and/or Derivatives Cash -7210.34 -0.22
USD USD CASH Cash and/or Derivatives Cash -133498.19 -4.08
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. nan nan nan nan nan